Skip to content

PHATPHATHOM PHARMACEUTICALS INC

CUSIP 71722W107 · common stock

1 tracked investor held PHATHOM PHARMACEUTICALS INC (PHAT) at the end of Q3 2026, worth $313.2K. The largest holder was Adar1 Capital Management, with 0.0% of its portfolio. Perceptive Advisors sold out of its position this quarter.

Holders · Q3 2026
1
New holders
0
Value held
$313.2K
Quarter-end price (est.)
$7.30

Investors holding PHAT · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.01%42,900$313.2KHOLD

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Perceptive Advisors0.09%532,000$5.8MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026101$313.2K$7.30
Q2 2026200$6.2M$10.85
Q1 2026210$10.8M$11.11
Q4 2025100$711.7K$16.59